Peripheral levels of inflammatory mediators in migraineurs during headache-free periods

Headache

Volumn 41, Issue 9, 2001, Pages 867-872

  Mohammadian, Parvaneh ^a   Hummel, Thomas ^c   Arora, Chander ^b   Carpenter, Thomas ^a  

^a Cleveland Chiropractic College   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF DRESDEN MEDICAL SCHOOL   (Germany)

Author keywords

Inflammatory mediators; Leukotriene; Migraine; Prostaglandin; Thromboxane

Indexed keywords

AUTACOID; LEUKOTRIENE B4; PROSTAGLANDIN E2; THROMBOXANE B2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; INFLAMMATION; MALE; MIGRAINE; NOSE MUCUS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SALIVA LEVEL; TRIGEMINAL NERVE;

EID: 0034761427     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2001.01158.x     Document Type: Article

References (17)

1. Vapaatalo H. Tolfenamic acid and migraine-aspects on prostaglandins and leukotrienes. Pharmacol Toxicol. 1994;75(suppl 2):76-80.
2. May A, Goadsby PJ. The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab. 1999;19: 115-127.
3. Shibata K, Osawa M, Iwata M. Pattern reversal visual evoked potentials in migraine with aura and migraine aura without headache. Cephalalgia. 1998;18:319-323.
4. Siniatchkin M, Gerber WD, Kropp P, Voznesenskaya T, Vein AM. Are the periodic changes of neurophysiological parameters during the pain-free interval in migraine related to abnormal orienting activity? Cephalalgia. 2000;20:20-29.
5. Grosser K, Oelkers R, Hummel T, et al. Olfactory and trigeminal event-related potentials in migraine. Cephalalgia. 2000;20:621-631.
6. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science. 1983;220:568-575.
7. Roth GJ, Siok CJ, Ozols J. Structural characteristics of prostaglandin synthetase from sheep vesicular gland. J Biol Chem. 1980;255:1301-1304.
8. Mizuno K, Yamamoto S, Lands WE. Effects of non-steroidal anti-inflammatory drugs on fatty acid cyclooxygenase and prostaglandin hydroperoxidase activities. Prostaglandins. 1982;23:743-757.
9. 2 from rat dura mater encephali following electrical and chemical stimulation in vitro. Neuroscience. 1999;89:901-907.
10. LaMancusa R, Pulcinelli FM, Ferroni P, et al. Blood leukotrienes in headache: correlation with platelet activity. Headache. 1991;31:409-414.
11. 2 in the saliva of common migraine patients. Action of calcium channel blockers. Headache. 1989;29:498-501.
12. Nattero G, Allais G, De Lorenzo C, et al. Relevance of prostaglandins in true menstrual migraine. Headache. 1989;29:233-238.
13. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):1-96.
14. Naclerio RM, Togias AG. The nasal allergic reaction: observations on the role of histamine. Clin Exp Allergy. 1991;21(suppl 2):13-19.
15. Mohammadian P, Schaefer D, Hummel T, Kobal G. Experimentally induced nasal irritation. Rhinology. 1999;37:175-178.
16. 2 levels in the saliva of common migrainous women. Headache. 1983;23:59-61.
17. Mezei Z, Kis B, Gecse A, et al. Platelet arachidonate cascade of migraineurs in the interictal phase. Platelets. 2000;11:222-225.